Exodus Point Capital Management, LP Seelos Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $46,428 - $69,496	-29,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.69 - $2.89 $56,621 - $96,826	-33,504 Reduced 53.43%	29,200 $70,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $165,538 - $396,289	62,704 New	62,704 $166,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.